Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Mr. Douglas B. NathansonExec. VP, Chief Development Officer, General Counsel & Corporate Secretary | -2,20k | 77,34k | Derivative Exercise and Sale | 35,07 - 35,24 | 17,72k | - |
| 2026-06-19 | Mr. Douglas B. NathansonExec. VP, Chief Development Officer, General Counsel & Corporate Secretary | -3,75k | 136,33k | Derivative Exercise and Sale | 36,38 | 17,72k | - |
| 2026-06-19 | Ms. Sandra SandersonCMO | -886,00 | 32,12k | Derivative Exercise and Sale | 36,26 | 1,50k | - |
| 2026-04-13 | Mr. Jo Mark ZurelDirector | 2,00k | 70,19k | Kauf | 35,10 | 7,00k | 40,00% |
| 2025-12-31 | Julia Michelle KnoxInsider | 82,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 39,26k | 0,21% |
| 2025-12-31 | Ms. Sandra SandersonCMO | 378,00 | 13,32k | Acquisition Under Employee Benefit Plan | 35,23 | 15,90k | 2,43% |
| 2025-12-31 | Mr. Douglas B. NathansonExec. VP, Chief Development Officer, General Counsel & Corporate Secretary | 438,00 | 15,35k | Acquisition Under Employee Benefit Plan | 35,05 | 21,72k | 2,06% |
| 2025-12-31 | Mr. Pierre St-LaurentCEO, President & Director | 40,00 | 1,57k | Acquisition Under Employee Benefit Plan | 39,34 | 5,07k | 0,80% |
| 2025-12-31 | Ms. Sandra PasquiniChief HR Officer | 26,00 | 969,56 | Acquisition Under Employee Benefit Plan | 37,29 | 4,20k | 0,62% |
| 2025-12-31 | Ms. Sandra SandersonCMO | 852,00 | 27,64k | Acquisition Under Employee Benefit Plan | 32,44 | 15,53k | 5,81% |
| 2025-12-31 | Mr. Douglas B. NathansonExec. VP, Chief Development Officer, General Counsel & Corporate Secretary | 889,00 | 28,83k | Acquisition Under Employee Benefit Plan | 32,43 | 21,28k | 4,36% |
| 2025-12-31 | Julia Michelle KnoxInsider | 1,23k | 44,09k | Acquisition Under Employee Benefit Plan | 35,90 | 1,23k | - |
| 2025-12-31 | Ms. Sandra PasquiniChief HR Officer | 417,00 | 13,66k | Acquisition Under Employee Benefit Plan | 32,77 | 4,17k | 11,10% |
| 2025-12-31 | Mr. Pierre St-LaurentCEO, President & Director | 626,00 | 23,55k | Acquisition Under Employee Benefit Plan | 37,63 | 5,03k | 14,23% |
| 2026-03-13 | Mr. Douglas B. NathansonExec. VP, Chief Development Officer, General Counsel & Corporate Secretary | -180,00 | 1,68k | Derivative Exercise and Sale | 26,49 - 35,85 | 20,65k | - |
| 2026-03-17 | Mr. Douglas B. NathansonExec. VP, Chief Development Officer, General Counsel & Corporate Secretary | -2,00k | 74,58k | Verkauf | 37,29 | 16,39k | -10,88% |
| 2026-03-13 | Ms. Sandra SandersonCMO | -14,40k | 524,01k | Verkauf | 36,39 | 274,00 | -98,13% |
| 2026-03-13 | Mr. Douglas B. NathansonExec. VP, Chief Development Officer, General Counsel & Corporate Secretary | 262,00 | 6,58k | Derivative Exercise and Retained Stock | 25,11 | 19,28k | 1,38% |
| 2026-03-13 | Mr. Douglas B. NathansonExec. VP, Chief Development Officer, General Counsel & Corporate Secretary | -2,26k | 83,56k | Verkauf | 35,84 - 37,09 | 19,28k | -10,50% |
| 2026-03-13 | Mr. Douglas B. NathansonExec. VP, Chief Development Officer, General Counsel & Corporate Secretary | -429,00 | 15,39k | Verkauf | 35,88 | 20,39k | -2,06% |
| 2026-03-13 | Mr. Douglas B. NathansonExec. VP, Chief Development Officer, General Counsel & Corporate Secretary | 429,00 | 10,84k | Derivative Exercise and Retained Stock | 25,27 | 20,39k | 2,15% |
| 2025-12-15 | Mr. Constantine PefanisExec. VP & CFO | 3,30k | 109,95k | Kauf | 33,32 | 36,30k | 10,00% |
| 2025-12-12 | Mr. Pierre St-LaurentCEO, President & Director | 3,00k | 99,78k | Kauf | 33,26 | 4,40k | 214,29% |
| 2025-12-12 | Mr. Jo Mark ZurelDirector | 4,00k | 134,94k | Kauf | 33,73 | 5,00k | 400,00% |
| 2025-11-05 | Mr. Pierre St-LaurentCEO, President & Director | 1,00 | 0,00 | Kauf | - | 1,00 | - |
| 2025-09-12 | Mr. Constantine PefanisExec. VP & CFO | 3,00k | 108,63k | Kauf | 36,21 | 33,00k | 10,00% |
| 2025-09-12 | Mr. Michael Bennett MedlineInsider | 6,00k | 0,00 | Kauf | - | 188,73k | 3,28% |
| 2025-08-01 | Ms. Sandra SandersonCMO | -6,50k | 259,50k | Verkauf | 39,92 | 14,67k | -30,70% |
| 2025-08-01 | Mr. Simon GagnéInsider | -8,80k | 348,10k | Verkauf | 39,57 | 0,00 | -100,00% |
| 2025-08-01 | Mr. Simon GagnéInsider | 8,80k | 0,00 | Derivative Exercise and Retained Stock | - | 0,00 | -100,00% |
| 2025-07-24 | Mr. Pierre St-LaurentCEO, President & Director | -7,01k | 286,94k | Verkauf | 40,87 - 41,10 | 1,40k | -83,34% |
| 2025-07-17 | Mr. Michael Bennett MedlineInsider | -2,00 | 81,60 | Verkauf | 40,80 | 182,73k | -0,00% |
| 2025-07-14 | Mr. Douglas B. NathansonExec. VP, Chief Development Officer, General Counsel & Corporate Secretary | -3,10k | 127,73k | Verkauf | 40,96 - 41,43 | 20,39k | -13,20% |
| 2025-07-14 | Mr. Michael Bennett MedlineInsider | -45,02k | 1,86M | Derivative Exercise and Sale | 41,30 | 182,74k | - |
| 2025-07-11 | Mr. Paul David SobeyIndependent Director | 14,33k | 569,35k | Kauf | 39,74 | 3,13M | 0,46% |
| 2025-07-11 | Mr. Paul David SobeyIndependent Director | -20,45k | 0,00 | Other Disposition | - | 3,13M | -0,65% |
| 2025-07-11 | Mr. David F. SobeyInsider | 28,65k | 1,14M | Kauf | 39,74 | - | - |
| 2025-07-11 | Dunvegan Holdings LimitedUnternehmen | 29,75k | 1,18M | Kauf | 39,74 | - | - |
| 2025-07-11 | Sumac Holdings LimitedUnternehmen | 31,59k | 1,26M | Kauf | 39,74 | - | - |
| 2025-07-10 | Mr. Michael Bennett MedlineInsider | -45,01k | 1,86M | Derivative Exercise and Sale | 41,42 | 182,74k | - |
| 2025-07-09 | Mr. Simon GagnéInsider | -4,48k | 182,20k | Verkauf | 40,72 | 0,00 | -100,00% |
| 2024-12-31 | Mr. Simon GagnéInsider | 41,00 | 1,09k | Acquisition Under Employee Benefit Plan | 26,63 | 0,00 | -100,00% |
| 2025-07-04 | Ms. Sandra SandersonCMO | -1,36k | 0,00 | Other Derivative Disposition | - | 31,09k | -4,19% |
| 2025-07-04 | Ms. Sandra PasquiniChief HR Officer | 3,04k | 0,00 | Derivative Exercise and Retained Stock | - | 3,76k | 426,05% |
| 2025-07-04 | Julia Michelle KnoxInsider | -1,17k | 0,00 | Other Derivative Disposition | - | 39,18k | -2,89% |
| 2025-07-04 | Ms. Sandra SandersonCMO | 2,07k | 0,00 | Derivative Exercise and Retained Stock | - | 21,17k | 10,82% |
| 2025-07-04 | Mr. Michael Bennett MedlineInsider | 21,75k | 0,00 | Derivative Exercise and Retained Stock | - | 182,74k | 13,51% |
| 2025-07-04 | Mr. Douglas B. NathansonExec. VP, Chief Development Officer, General Counsel & Corporate Secretary | 3,94k | 0,00 | Derivative Exercise and Retained Stock | - | 23,49k | 20,15% |
| 2025-07-04 | Mr. Simon GagnéInsider | 4,43k | 0,00 | Derivative Exercise and Retained Stock | - | 4,48k | 10.814,63% |
| 2025-07-04 | Mr. Pierre St-LaurentCEO, President & Director | 8,41k | 0,00 | Derivative Exercise and Retained Stock | - | 8,41k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
